Besides the mutations, copy number amplification the gene can also be observed in around 20% of the testicular germ cell tumors (TGCTs) and ovarian cancers (OVs), which may also confer the tumor cells to a KRAS gain-of-function shift in the cellular phenotype. Here, KRAS is linked to ovarian cancer.